IQVIA Strengths, Domain Expertise, and Key Differentiators
IQVIA was formed through the merger of IMS Health and Quintiles, combining strengths in advanced analytics, technology solutions, and clinical research. Leveraging one of the world's largest curated healthcare data sets—including over one billion non-identified patient records across prescriptions, medical claims, genomics, and social media—IQVIA enables smarter decision-making in healthcare.
Its mission is to deliver actionable insights and execution capabilities to a broad range of stakeholders, including biopharmaceutical companies, researchers, government agencies, and payers. With data covering 85% of global pharmaceutical sales (as of 2019), IQVIA offers unique, hard-to-replicate intelligence that drives innovation in disease understanding, human behavior, and scientific advancement. The company’s value lies not just in the scale of its data, but in its ability to translate that data into meaningful impact across the healthcare ecosystem.
IQVIA Recent Developments
Between 2023 and 2025, IQVIA launched several technology-driven solutions, including the IQVIA AI Assistant for life sciences insights, SmartSolve eQMS for quality management, and the Health Research Space platform for patient data collection. It also introduced a GenAI Writing Tool for marketing content and partnered with Salesforce to integrate its Orchestrated Customer Engagement (OCE) platform with Salesforce Life Sciences Cloud. Additionally, IQVIA supported global health initiatives such as a digital health blueprint for Africa and disease outbreak mapping in Brazil.
IQVIA Mergers and Acquisitions (M&A) Activities
In October 2022, IQVIA completed its acquisition of Lasso Marketing, a leading omnichannel healthcare marketing and analytics platform. Founded in 2019 and based in Austin, Texas, Lasso provides comprehensive solutions for the planning, execution, measurement, and optimization of consumer-targeted campaigns. Its capabilities span multiple channels, including programmatic advertising, email, social media, and connected TV.
IQVIA Customers in ARTW Customer Database
Leveraging a rigorous data-centric research methodology, APPS RUN THE WORLD asks the simple question: Who’s buying IQVIA applications and why? And we provide the answers – supported by decades of research – to our clients around the world. Our Customer database has over 100 data fields that detail company usage of IQVIA and other enterprise apps by function, customer size, industry, location, implementation status, partner involvement, Line of Business Key Stakeholders and IT decision makers contact details. List of Verified IQVIA Planning Suite,IQVIA Connected Intelligence, IQVIA One Home for Sites, IQVIA Patient Suite, customers.
IQVIA Overview
2400 Ellis Road
Durham, NC, 27703, United States
1 919-998-2000
https://www.iqvia.com/
Ownership: - NYSE: IQV
Number of Employees: 89000
Functional Markets: Analytics and BI, Collaboration, Content Management, CRM, ERP Financial, ERP Services and Operations, PLM, Procurement, SPM, SCM, TRM,
Key Verticals: Healthcare, Life Sciences,
IQVIA Key Enterprise and Cloud Applications
IQVIA Planning Suite,IQVIA Connected Intelligence, IQVIA One Home for Sites, IQVIA Patient Suite,
IQVIA Revenues, $M:
| Type/Year | 2023 | 2024 | YoY Growth, % |
|---|---|---|---|
| Total Revenues, $M | Subscribe | Subscribe | Subscribe |
| Enterprise Applications Revenues, $M | Subscribe | Subscribe | Subscribe |
| Cloud Applications Revenues, $M | Subscribe | Subscribe | Subscribe |
* Enterprise Applications Revenues = License + Support & Maintenance + SaaS
** All revenue figures are estimates based on public records, Cloud and Non-Cloud business models in Apps Run The World's vendor database, and annual survey results including vendor feedback.
IQVIA Revenue Breakdown By Type, $M:
IQVIA Enterprise Applications Revenues By Functional Markets, $M:
IQVIA Enterprise Applications Revenues By Verticals, $M:
IQVIA Revenues By Region, $M
| Region | % of Total Revenues | 2024 Total Revenues, $M | 2024 Enterprise Applications Revenues, $M | 2024 Cloud Applications Revenues, $M |
|---|---|---|---|---|
| Americas | Subscribe | Subscribe | Subscribe | Subscribe |
| EMEA | Subscribe | Subscribe | Subscribe | Subscribe |
| APAC | Subscribe | Subscribe | Subscribe | Subscribe |
| Total | Subscribe | Subscribe | Subscribe | Subscribe |
IQVIA Direct vs Indirect sales
| Type | Direct Sales | Indirect Sales | Total |
|---|---|---|---|
| Type % | Subscribe | Subscribe | Subscribe |
| Revenues, $M | Subscribe | Subscribe | Subscribe |
IQVIA Customers - Breakdown by Geo, Size, Vertical and Product
List of Verified IQVIA Customers
No. of IQVIA Customers: x
No. of IQVIA Enterprise Applications Customers: x
No. of IQVIA Cloud Customers: x
No. of IQVIA Cloud Subscribers: x
IQVIA operates in over 100 countries, serving thousands of clients across the global healthcare ecosystem. Its diverse customer base includes pharmaceutical and biotechnology companies, medical device manufacturers, healthcare providers, government and public health agencies, payers, insurers, and academic research institutions—underscoring its leadership in health data, analytics, and technology solutions.
IQVIA Market Opportunities, M&A and Geo Expansions
At the beginning of 2025, IQVIA made a strategic collaboration with NVIDIA to help realize the potential of AI in healthcare and life sciences. The healthcare and life sciences industries generate vast amounts of data, representing significant potential for AI-powered solutions. This collaboration between IQVIA and NVIDIA will help accelerate IQVIA Healthcare-grade AI, enabling new levels of agentic automation of complex and time-consuming workflows across the therapeutic life cycle with the precision, scalability, and trust required by IQVIA’s customers. IQVIA has been leading in the responsible use of AI, ensuring that its AI-powered capabilities are grounded in privacy, regulatory compliance, and patient safety. IQVIA Healthcare-grade AI represents the company’s commitment to these principles.
IQVIA Risks and Challenges
Operating in a highly regulated environment, IQVIA faces risks related to changes in healthcare laws and data privacy regulations. Non-compliance can result in increased costs and constraints on operations.
IQVIA Ecosystem, Partners, Resellers and SI
In May 2025, IQVIA announced a strategic collaboration with SCRI Development Innovations, the contract research organization arm of the Sarah Cannon Research Institute. This partnership aims to transform global oncology clinical trials by integrating IQVIA's global data and technology capabilities with SCRI's community-based expertise and its Accelero operational model. The collaboration is designed to streamline trial operations, enhance site recruitment, and expedite data delivery, ultimately accelerating patient access to advanced cancer therapies.
Research Methodology
Data used in research reports are derived from publicly available documents, continuous surveys of applications vendors, customers, resellers, Independent Software Vendors, systems integrators and other verifiable sources.
Vendor shares and market forecast results are based on a combination of existing databases as well as demand side and supply side research conducted throughout the year with validation from vendors, customers, channel partners and documentations such as earnings releases and 10Q and 10K filings, vertical industry studies, regional and country-level statistics from public and private institutions(i.e. colleges, universities, government agencies and trade associations).
For additional information on our methodologies, here's the link:
https://www.appsruntheworld.com/About Ushttps://www.appsruntheworld.com/taxonomy
https://www.appsruntheworld.com/FAQ
